Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jan 7, 2008; 14(1): 85-89
Published online Jan 7, 2008. doi: 10.3748/wjg.14.85
Published online Jan 7, 2008. doi: 10.3748/wjg.14.85
Index serum CRP level during relapse (mg/L) | ≤15 | > 15 | P-value |
LCRP | HCRP | ||
n | 27 | 67 | |
Time of follow-up, yr (SD) | 10.8 (4.0) | 10.3 (3.7) | NS |
Demographic factors | |||
Sex: men | 12 (44.4%) | 32 (47.7%) | NS |
Mean age, yr (SD) | 45 (13.5) | 42 (11.0) | NS |
Clinical features | |||
Age at time of diagnosis (SD) | 27.0 (8.3) | 27.4 (10.8) | NS |
Duration of disease, yr (SD) | 18.0 (10.2) | 14.3 (7.3) | NS |
Localization | |||
Terminal ileum | 6 (22.2%) | 8 (11.9%) | NS |
Colon | 7 ( 25.9%) | 31 (46.2%) | |
Ileocolon | 13 (48.1%) | 26 (38.8%) | |
Upper gastrointestinal | 1 (3.7%) | 2 (3.0%) | |
Behaviour | |||
Non-stricturing non penetrating | 13 (48.1%) | 26 (38.8%) | NS |
Stricturing | 7 (25.9%) | 15 (22.4%) | |
Penetrating | 7 (25.9%) | 26 (38.8%) |
Index serum CRP level during relapse (mg/L) | ≤15 | > 15 | P-value |
LCRP | HCRP | ||
Clinical findings | |||
Mean number of relapses per year (SD) | 0.25 (0.16) | 0.36 (0.24) | < 0.05 |
Mean severity of the index relapse according to endoscopic reports, on a 10 points visual analogue scale (SD) | 3.18 (1.09) | 4.39 (1.24) | < 0.001 |
Drug use | |||
Number of patients with prednisone use | 23 (85.2%) | 62 (92.5%) | NS |
Mean number of days of prednisone use per year (SD)1 | 58 (48) | 107 (95) | < 0.05 |
Surgeries | |||
Number of patients who underwent ≥ 1 surgeries | 12 (44.4%) | 27 (37.3) | NS |
Total number of surgeries23 | 2.0 (0.6) | 1.7 (0.09) | NS |
Related factors | |||
Smoking: n | 23 | 58 | |
smokers | 8 (34.8%) | 24 (41.4%) | NS |
non-smokers | 11 (47.8%) | 24 (41.4%) | |
quitted smokers | 4 (17.4%) | 10 (17.2%) | |
Presence of granulomas: n | 22 | 51 | |
8 (36.4%) | 25 (49.0%) | NS |
- Citation: Koelewijn CL, Schwartz MP, Samsom M, Oldenburg B. C-reactive protein levels during a relapse of Crohn’s disease are associated with the clinical course of the disease. World J Gastroenterol 2008; 14(1): 85-89
- URL: https://www.wjgnet.com/1007-9327/full/v14/i1/85.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.85